Mannkind (MNKD) Retained Earnings (2010 - 2026)
Mannkind's (MNKD) quarterly Retained Earnings came in at -$3.2 billion in Q1 2026, down 273743.53% year-on-year from N/an in Q1 2025, and down 0.52% on a QoQ basis from -$3.2 billion in Q4 2025.
Mannkind (MNKD) Retained Earnings (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Retained Earnings data on file, last reported at -$3.2 billion in Q1 2026.
- On a quarterly basis, Retained Earnings fell 273743.53% year-over-year to -$3.2 billion in Q1 2026; TTM through Mar 2026 was -$3.2 billion, a 273743.53% decrease from a year earlier, with the FY2025 full-year figure at -$3.2 billion, down 288283.59% from the prior year.
- Retained Earnings for Q1 2026 stood at -$3.2 billion, down from -$3.2 billion in the prior quarter.
- Over the last five years, Retained Earnings for MNKD reached as high as $1.3 million in Q2 2025 and fell as low as -$3.2 billion in Q4 2023.
- Historically, Retained Earnings has averaged -$2.1 billion across 5 years, with a median of -$3.2 billion in 2022.
- Across the five-year window, Retained Earnings plunged 727140.86% in 2024 and jumped 100.04% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$3.2 billion in 2022, then decreased by 0.37% to -$3.2 billion in 2023, then jumped by 100.03% to $1.1 million in 2024, then plunged by 288283.59% to -$3.2 billion in 2025, then retreated by 0.52% to -$3.2 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$3.2 billion in Q1 2026, -$3.2 billion in Q4 2025, and -$3.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -3.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.21 Bn |
| Dec 31, 2025 | -3.20 Bn |
| Sep 30, 2025 | -3.18 Bn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 588,000.00 |
| Jun 30, 2024 | -3.22 Bn |
| Mar 31, 2024 | -3.22 Bn |
| Dec 31, 2023 | -3.23 Bn |
| Sep 30, 2023 | 443,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | -3.23 Bn |
| Dec 31, 2022 | -3.22 Bn |
| Sep 30, 2022 | -3.20 Bn |
| Jun 30, 2022 | -3.20 Bn |
| Mar 31, 2022 | -3.20 Bn |
| Dec 31, 2021 | -3.13 Bn |
| Sep 30, 2021 | -3.10 Bn |
| Jun 30, 2021 | -3.10 Bn |